June 15, 2020 / 1:36 PM / a month ago

BRIEF-Edesa Biotech Receives Regulatory Approval To Initiate COVID-19 Study

June 15 (Reuters) - Edesa Biotech Inc:

* EDESA BIOTECH RECEIVES REGULATORY APPROVAL TO INITIATE COVID-19 STUDY

* EDESA BIOTECH - GOT EXPEDITED APPROVAL FROM HEALTH CANADA TO BEGIN PHASE 2/3 CLINICAL STUDY OF EB05 AS TREATMENT FOR MODERATE TO SEVERE COVID-19 PATIENTS

* EDESA BIOTECH - HAS EB05 DRUG PRODUCT AVAILABLE NOW, SEEKING GOVERNMENT GRANTS TO ACCELERATE INITIATION & ROLLOUT OF STUDY, BEGINNING AT UP TO 30 SITES Source text: (bit.ly/30KUl82) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below